LAUREN LANIER: Open Payments
NPI 1356856272 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 84 payments from 18 companies in 2025. Trend: 2023 $3,178 · 2024 $3,399 · 2025 $1,746
Food & beverage: $1,746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $380 |
| ABBVIE INC. | 15 | $313 |
| PFIZER INC. | 14 | $215 |
| Lilly USA, LLC | 7 | $152 |
| Dexcom, Inc. | 6 | $138 |
| Phathom Pharmaceuticals, Inc. | 5 | $98 |
| Novo Nordisk Inc | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $53 |
Products named: AIRSUPRA, NURTEC ODT, VRAYLAR, Dexcom G6 Transmitter, MOUNJARO, QULIPTA, FARXIGA, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
